Posted by Michael Wonder on 15 May 2019
Proposal to widen access to pertussis (whooping cough) vaccine
14 May 2019 - PHARMAC is seeking feedback on a proposal to widen access to funded pertussis (whooping cough) vaccine for all pregnant women at any time during their pregnancy, as well as for parents of infants admitted to a Neonatal Intensive Care Unit or Specialist Care Baby Unit for more than 3 days.
This would be achieved by widening access to the diphtheria, tetanus and pertussis vaccine (DTaP; funded brand name Boostrix) in Section I and Part II of Section H of the Pharmaceutical Schedule from 1 July 2019.
